The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) aims to develop a framework for functional mapping the human body with cellular resolution to enhance our understanding of cellular organization-function. HuBMAP will accelerate the development of the next generation of tools and techniques to generate 3D tissue maps using validated high-content, high-throughput imaging and omics assays, and establish an open data platform for integrating, visualizing data to build multi-dimensional maps.
New RFA to support Academic-Industrial Partnerships for technologies to capture and quantify tumor associated cells, DNA, RNA, or exosomes in body fluids of patients with early stage disease or those at high risk of cancer.
NCI’s Office of Cancer Nanotechnology Research has published a new funding opportunity announcement for the Innovative Research in Cancer Nanotechnology (IRCN) initiative, PAR-17-240. All IRCN awards made through this announcement will be part of the Alliance for Nanotechnology in Cancer network. Due dates are twice per year, with the announcement remaining open until May 2020. The first due date is November 21, 2017.
In direct response to Vice President Biden’s Cancer Moonshot, Atlanta-based Global Center for Medical Innovation (GCMI) and T3 Labs are collaborating with the National Cancer Institute (NCI) to accelerate development of innovative cancer diagnostic devices from the lab to the marketplace. This collaboration seeks to maximize the value of taxpayer investments through a cost-effective platform for designing, engineering, and testing diagnostic technologies.
Principal Investigator: Ruedi Aebersold
Organization: University of Washington (now with Institute of Molecular Systems Biology, ETH Zurich)
Years of Grant(s): 2000-2002
IMAT and ITCR launching a new effort to catalyze collaborations across the two programs. Contact Tony Dickherber for details.
An extensive impact assessment of the IMAT program was recently completed by a professional evaluation firm (Ripple Effect Communications, Inc). NCI is thankful to all investigators that assisted with these efforts. The full report can be downloaded here. Please contact Tony Dickherber for all inquiries associated with this report.
Review of single molecule nucleic acid analysis using micro- and nano-fluidic platforms in Lab on a Chip
Haplotyping via high-throughput, linked-read sequencing with small input DNA requirements in Nature Biotechnology
Advancing Molecular Ion Beam Imaging platform in Nature Methods.